Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (1): 6-11.doi: 10.3969/j.issn.1000-6621.2021.01.003

• 重磅 • 上一篇    下一篇



  • 收稿日期:2020-12-14 出版日期:2021-01-10 发布日期:2021-01-12
  • 基金资助:

Tuberculosis research progress in 2020

Chinese Antituberculosis Association   

  • Received:2020-12-14 Online:2021-01-10 Published:2021-01-12



关键词: 分枝杆菌,结核, 研究类型, 综述文献(主题)


Tuberculosis (TB) is one of the most serious infectious diseases, and one of the top ten death causes of single infectious disease globally. In 2020, researchers have made many efforts, and many breakthroughs have been made in basic research, diagnosis, treatment and prevention on TB. These breakthroughs have brought a lot of inspiration and ideas to TB research, and also brought more hope for clinical work. For example, the research on the cough mechanism of MTB sulfolipid-1 has brought new ideas to control the infection of MTB. The good protective effect of M72/AS01E vaccine gave us hope for TB prevention after BCG. The results of the Nix-TB study bring new light to the retreated or refractory MDR/XDR-TB patients. New diagnostic methods such as mRNA markers are also making progress. In order to improve the diagnosis and treatment ability of national TB prevention and control personnel, and timely understand the breakthrough of global TB research in new technologies, new methods, new concepts and new drug research, Chinese Antituberculosis Association organized experts to interpret the important literatures published internationally from October 2019 to October 2020, so as to contribute to promoting the research work in the field of TB in China.

Key words: Mycobacterium tuberculosis, Study characteristics, Review literature as topic